Literature DB >> 10731438

Telomerase activity in rat cardiac myocytes is age and gender dependent.

A Leri1, A Malhotra, C C Liew, J Kajstura, P Anversa.   

Abstract

Telomerase replaces telomeric repeat DNA lost during the cell cycle, restoring telomere length. This enzyme is present only during cell replication and its activity reflects the extent of proliferation. Whether cardiac myocytes are terminally differentiated cells is still a highly controversial issue, and the possibility of myocyte division is frequently rejected. On this basis, telomerase was measured in pure preparations of myocytes, isolated from rats throughout their lifespan. Fetal and neonatal rat myocytes were used as positive control cells. Contrary to expectation, the authors report that telomerase activity was detectable in pure preparations of young adult, fully mature adult, and senescent ventricular myocytes, defeating the dogma that this cell population is permanent and irreplaceable. Aging decreased 31% telomerase activity in male myocytes. An opposite effect occurred in female myocytes in which this enzyme increased 72%. This differential adaptation between the two genders in the rat model may be relevant to observations in humans; myocyte loss occurs in men as a function of age, whereas myocyte number is preserved in women. The greater growth potential of female myocytes may be critical for the longer lifespan and decreased incidence of heart failure in women. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10731438     DOI: 10.1006/jmcc.1999.1084

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  16 in total

1.  Telomerase expression and activity are coupled with myocyte proliferation and preservation of telomeric length in the failing heart.

Authors:  A Leri; L Barlucchi; F Limana; A Deptala; Z Darzynkiewicz; T H Hintze; J Kajstura; B Nadal-Ginard; P Anversa
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-10       Impact factor: 11.205

2.  Chronic stress elevates telomerase activity in rats.

Authors:  Annaliese K Beery; Jue Lin; Joshua S Biddle; Darlene D Francis; Elizabeth H Blackburn; Elissa S Epel
Journal:  Biol Lett       Date:  2012-10-10       Impact factor: 3.703

3.  Experimental manipulation of telomere length: does it reveal a corner-stone role for telomerase in the natural variability of individual fitness?

Authors:  F Criscuolo; S Smith; S Zahn; B J Heidinger; M F Haussmann
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2018-03-05       Impact factor: 6.237

Review 4.  Molecular mechanisms of cardiomyocyte aging.

Authors:  Anna Sheydina; Daniel R Riordon; Kenneth R Boheler
Journal:  Clin Sci (Lond)       Date:  2011-10       Impact factor: 6.124

Review 5.  Role of stem cells in cardiovascular biology.

Authors:  T Hosoda; M Rota; J Kajstura; A Leri; P Anversa
Journal:  J Thromb Haemost       Date:  2011-07       Impact factor: 5.824

6.  Modulation of sarcoplasmic reticulum Ca(2+) cycling in systolic and diastolic heart failure associated with aging.

Authors:  Andrzej M Janczewski; Edward G Lakatta
Journal:  Heart Fail Rev       Date:  2010-09       Impact factor: 4.214

7.  The longest telomeres: a general signature of adult stem cell compartments.

Authors:  Ignacio Flores; Andres Canela; Elsa Vera; Agueda Tejera; George Cotsarelis; María A Blasco
Journal:  Genes Dev       Date:  2008-02-18       Impact factor: 11.361

Review 8.  Mitochondria and oxidative stress in heart aging.

Authors:  Beatriz Martín-Fernández; Ricardo Gredilla
Journal:  Age (Dordr)       Date:  2016-07-24

Review 9.  The roles of senescence and telomere shortening in cardiovascular disease.

Authors:  Frej Fyhrquist; Outi Saijonmaa; Timo Strandberg
Journal:  Nat Rev Cardiol       Date:  2013-03-12       Impact factor: 32.419

Review 10.  Effects of biological sex on the pathophysiology of the heart.

Authors:  Loubina Fazal; Feriel Azibani; Nicolas Vodovar; Alain Cohen Solal; Claude Delcayre; Jane-Lise Samuel
Journal:  Br J Pharmacol       Date:  2014-02       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.